Verification of the efficacy of intravaginal ulinastatin administration in patients with cervical shortening
Not Applicable
Completed
- Conditions
- Pregnant women with subclinical infection and cervical length &#6160325 mm as diagnosed by transvaginal ultrasonography in a maternity health examination conducted during the second trimester of pregnancy (between week 16 day 0 and week 26 day 6 of gestation)
- Registration Number
- JPRN-UMIN000001871
- Lead Sponsor
- Japan Organization of Prevention of Preterm Delivery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Multiple pregnancy involving more than 3 fetuses (2) Placenta previa (3) Premature separation of normally implanted placenta (4) Serious fetal abnormality (5) Patients in whom fetal well-being cannot be confirmed (6) Patients who previously underwent cervical cerclage during current pregnancy (7) Patients with signs of threatened premature delivery*2 (8) Patients with complications of psychiatric disease or psychiatric symptoms whose participation in the trial is judged to be infeasible (9) Other patients judged to be ineligible by attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method